Bhuiyan P, Sun Z, Khan M, Hossain M, Rahman M, Qian Y
Heliyon. 2024; 10(3):e25191.
PMID: 38322840
PMC: 10844262.
DOI: 10.1016/j.heliyon.2024.e25191.
Mahadevan A, Cornblath E, Lydon-Staley D, Zhou D, Parkes L, Larsen B
Mol Psychiatry. 2023; 28(8):3314-3323.
PMID: 37353585
PMC: 10618098.
DOI: 10.1038/s41380-023-02121-z.
Reynolds G
J Neural Transm (Vienna). 2021; 129(5-6):643-647.
PMID: 34935080
PMC: 9188531.
DOI: 10.1007/s00702-021-02453-6.
Piyabhan P, Tingpej P, Duansak N
Neuropsychiatr Dis Treat. 2019; 15:1103-1117.
PMID: 31118643
PMC: 6503340.
DOI: 10.2147/NDT.S193222.
Marunnan S, Pulikkal B, Jabamalairaj A, Bandaru S, Yadav M, Nayarisseri A
Curr Neuropharmacol. 2016; 15(8):1085-1092.
PMID: 27919211
PMC: 5725540.
DOI: 10.2174/1567201814666161205131745.
Epigenetic Regulation of Glutamic Acid Decarboxylase 67 in a Hippocampal Circuit.
Subburaju S, Coleman A, Cunningham M, Ruzicka W, Benes F
Cereb Cortex. 2016; 27(11):5284-5293.
PMID: 27733539
PMC: 6411031.
DOI: 10.1093/cercor/bhw307.
Cell-based therapies for the treatment of schizophrenia.
Donegan J, Lodge D
Brain Res. 2016; 1655:262-269.
PMID: 27544423
PMC: 5474910.
DOI: 10.1016/j.brainres.2016.08.010.
In Sickness and in Health: Perineuronal Nets and Synaptic Plasticity in Psychiatric Disorders.
Pantazopoulos H, Berretta S
Neural Plast. 2016; 2016:9847696.
PMID: 26839720
PMC: 4709762.
DOI: 10.1155/2016/9847696.
Using human brain imaging studies as a guide toward animal models of schizophrenia.
Bolkan S, Carvalho Poyraz F, Kellendonk C
Neuroscience. 2015; 321:77-98.
PMID: 26037801
PMC: 4664583.
DOI: 10.1016/j.neuroscience.2015.05.055.
GABA abnormalities in schizophrenia: a methodological review of in vivo studies.
Taylor S, Tso I
Schizophr Res. 2014; 167(1-3):84-90.
PMID: 25458856
PMC: 4409914.
DOI: 10.1016/j.schres.2014.10.011.
Selective loss of parvalbumin-positive GABAergic interneurons in the cerebral cortex of maternally stressed Gad1-heterozygous mouse offspring.
Uchida T, Furukawa T, Iwata S, Yanagawa Y, Fukuda A
Transl Psychiatry. 2014; 4:e371.
PMID: 24618690
PMC: 3966041.
DOI: 10.1038/tp.2014.13.
Perinatal phencyclidine administration decreases the density of cortical interneurons and increases the expression of neuregulin-1.
Radonjic N, Jakovcevski I, Bumbasirevic V, Petronijevic N
Psychopharmacology (Berl). 2013; 227(4):673-83.
PMID: 23380917
DOI: 10.1007/s00213-013-2999-7.
A loss of hippocampal perineuronal nets produces deficits in dopamine system function: relevance to the positive symptoms of schizophrenia.
Shah A, Lodge D
Transl Psychiatry. 2013; 3:e215.
PMID: 23321812
PMC: 3566725.
DOI: 10.1038/tp.2012.145.
The role of glutamatergic inputs onto parvalbumin-positive interneurons: relevance for schizophrenia.
Rotaru D, Lewis D, Gonzalez-Burgos G
Rev Neurosci. 2012; 23(1):97-109.
PMID: 22718616
PMC: 3607105.
DOI: 10.1515/revneuro-2011-0059.
Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies.
Stan A, Lewis D
Curr Pharm Biotechnol. 2012; 13(8):1557-62.
PMID: 22283765
PMC: 3345302.
DOI: 10.2174/138920112800784925.
The axon initial segment in nervous system disease and injury.
Buffington S, Rasband M
Eur J Neurosci. 2011; 34(10):1609-19.
PMID: 22103418
PMC: 3482160.
DOI: 10.1111/j.1460-9568.2011.07875.x.
Neural models of schizophrenia.
Heckers S
Dialogues Clin Neurosci. 2011; 2(3):267-79.
PMID: 22033839
PMC: 3181608.
Amygdala abnormalities in first-degree relatives of individuals with schizophrenia unmasked by benzodiazepine challenge.
Wolf D, Satterthwaite T, Loughead J, Pinkham A, Overton E, Elliott M
Psychopharmacology (Berl). 2011; 218(3):503-12.
PMID: 21603892
PMC: 3962022.
DOI: 10.1007/s00213-011-2348-7.
The chandelier neuron in schizophrenia.
Lewis D
Dev Neurobiol. 2010; 71(1):118-27.
PMID: 21154915
PMC: 3116957.
DOI: 10.1002/dneu.20825.
Abnormal structure or function of the amygdala is a common component of neurodevelopmental disorders.
Schumann C, Bauman M, Amaral D
Neuropsychologia. 2010; 49(4):745-59.
PMID: 20950634
PMC: 3060967.
DOI: 10.1016/j.neuropsychologia.2010.09.028.